Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ben Kearns"'
Autor:
Jessica Li, Mark Green, Ben Kearns, Eleanor Holding, Christine Smith, Annette Haywood, Cindy Cooper, Mark Strong, Clare Relton
Publikováno v:
BMC Public Health, Vol 16, Iss 1, Pp 1-9 (2016)
Abstract Background Multimorbidity is increasingly being recognized as a serious public health concern. Research into its determinants, prevalence, and management is needed and as the risk of experiencing multiple chronic conditions increases over ti
Externí odkaz:
https://doaj.org/article/ada49144ef6c4de8803e6a79da4ce0a6
Autor:
Stephen Palmer, Isabelle Borget, Tim Friede, Don Husereau, Jonathan Karnon, Ben Kearns, Emma Medin, Elisabeth F.P. Peterse, Sven L. Klijn, Elisabeth J.M. Verburg-Baltussen, Elisabeth Fenwick, John Borrill
Publikováno v:
Value in Health. 26:185-192
Parametric models are routinely used to estimate the benefit of cancer drugs beyond trial follow-up. The advent of immune checkpoint inhibitors has challenged this paradigm, and emerging evidence suggests that more flexible survival models, which can
Autor:
Ben Kearns
Publikováno v:
Wiley StatsRef: Statistics Reference Online. :1-6
Autor:
John Stevens, Helen Bell Gorrod, Ben Kearns, Nicholas Latimer, Praveen Thokala, David Tyas, Alexander Labeit, Ahmed Sowdani
Publikováno v:
Medical Decision Making. 39:899-909
Objectives. In June 2011, the National Institute for Health and Care Excellence (NICE) Decision Support Unit published a Technical Support Document (TSD) providing recommendations on survival analysis for NICE technology appraisals (TAs). Survival an
Publikováno v:
BMC Public Health
BMC Public Health, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Public Health, Vol 21, Iss 1, Pp 1-9 (2021)
Background The relationship between obesity and health-related quality of life (HRQoL) may be confounded by factors such as multimorbidity. The aim of the study was to explore this relationship, controlling for long-term conditions and other health,
Autor:
Andrew B. Lindstrom, Mark J. Strynar, Detlef R.U. Knappe, Michael Richardson, Elisa Arevalo, Mei Sun, Chris Smith, Adam Pickett, Ben Kearns
Publikováno v:
Environmental Science & Technology Letters. 3:415-419
Long-chain per- and polyfluoroalkyl substances (PFASs) are being replaced by short-chain PFASs and fluorinated alternatives. For ten legacy PFASs and seven recently discovered perfluoroalkyl ether carboxylic acids (PFECAs), we report (1) their occurr
Autor:
Christine Smith, Eleanor Holding, Annette Haywood, Mark A. Green, Mark Strong, Ben Kearns, Cindy Cooper, Clare Relton, Jessica Li
Publikováno v:
BMC Public Health, Vol 16, Iss 1, Pp 1-9 (2016)
BMC Public Health
BMC PUBLIC HEALTH
BMC Public Health
BMC PUBLIC HEALTH
Background Multimorbidity is increasingly being recognized as a serious public health concern. Research into its determinants, prevalence, and management is needed and as the risk of experiencing multiple chronic conditions increases over time, atten
Publikováno v:
BMC Medicine
Europe PubMed Central
Europe PubMed Central
Background The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) was the biggest ovarian cancer screening trial to date. A non-significant effect of screening on ovarian cancer was reported, but the authors noted a potential de
Autor:
Ben Kearns, Michael J. Campbell, Roberta Ara, Keith R. Abrams, Mónica Hernández Alava, Andrea Manca, Allan Wailoo
Publikováno v:
PharmacoEconomics. 31:643-652
Decision-analytic models (DAMs) used to evaluate the cost effectiveness of interventions are pivotal sources of evidence used in economic evaluations. Parameter estimates used in the DAMs are often based on the results of a regression analysis, but t
Publikováno v:
PharmacoEconomics. 31:479-488
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of cabazitaxel (Jevtana®, sanofi-aventis, UK) to submit evidence of its clinical and cost effectiveness for the second-line treatment of metastatic hormone-ref